{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:12:18Z","timestamp":1794471138480,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":2404,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1111\/j.1469-0691.2008.01983.x","type":"journal-article","created":{"date-parts":[[2008,4,22]],"date-time":"2008-04-22T19:25:42Z","timestamp":1208892342000},"page":"65-70","source":"Crossref","is-referenced-by-count":44,"special_numbering":"S4","title":["Combination antifungal therapy: a critical review of the evidence"],"prefix":"10.1016","volume":"14","author":[{"given":"L.","family":"Ostrosky-Zeichner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2008.01983.x_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/497138","article-title":"The changing face of fungal infections in health care settings","volume":"41","author":"Fridkin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib5","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF01713042","article-title":"A randomized study comparing fluconazole with amphotericin B\/5-flucytosine for the treatment of systemic candida infections in intensive care patients","volume":"24","author":"Abele-Horn","year":"1996","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/apc.1998.12.681","article-title":"Candidal meningitis in HIV-infected patients","volume":"12","author":"Casado","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/clinids\/6.6.791","article-title":"Combined therapy with amphotericin B and 5-fluorocytosine for candida meningitis","volume":"6","author":"Smego","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/13693780600684494","article-title":"Late-onset invasive aspergillosis in organ transplant recipients in the current era","volume":"44","author":"Singh","year":"2006","journal-title":"Med Mycol"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib15","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-1161","article-title":"Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000","volume":"117","author":"Zaoutis","year":"2006","journal-title":"Pediatrics"},{"issue":"suppl 3","key":"10.1111\/j.1469-0691.2008.01983.x_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1399-3062.4.s3.5.x","article-title":"Diagnosis of fungal infection: new technologies for the mycology laboratory","volume":"4","author":"Alexander","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib18","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/cncr.21057","article-title":"Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis","volume":"103","author":"Kontoyiannis","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1201-9712(99)90038-3","article-title":"Amphotericin B with and without itraconazole for invasive aspergillosis: a three-year retrospective study","volume":"3","author":"Popp","year":"1999","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib21","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (COMBISTRAT trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"issue":"suppl 4","key":"10.1111\/j.1469-0691.2008.01983.x_bib22","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/421951","article-title":"The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview","volume":"39","author":"Rex","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib23","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01983.x_bib24","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.01983.x_bib25","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1080\/13693780500052099","article-title":"Cytokines in host defense against aspergillus: recent advances","volume":"43","author":"Phadke","year":"2005","journal-title":"Med Mycol"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.01983.x_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.12-S2-2","article-title":"Difficulties with fungal infections in acute myelogenous leukemia patients: immune enhancement strategies","volume":"12","author":"Safdar","year":"2007","journal-title":"Oncologist"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14616189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14616189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T17:01:54Z","timestamp":1588611714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14616189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":26,"alternative-id":["S1198743X14616189"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2008.01983.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}